Thursday, August 7, 2025

Approach to Acute Desaturation in a Ventilated Patient

 

Approach to Acute Desaturation in a Ventilated Patient: A Systematic Clinical Review

Dr Neeraj Manikath , claude.ai

Abstract

Acute desaturation in mechanically ventilated patients represents a critical emergency requiring immediate systematic assessment and intervention. This review presents an evidence-based approach to the evaluation and management of acute oxygen desaturation in ventilated patients, emphasizing the DOPE mnemonic (Displacement, Obstruction, Pneumothorax, Equipment failure) as a structured framework for rapid diagnosis. We discuss bedside troubleshooting techniques, immediate interventions preceding arterial blood gas analysis, and provide clinical pearls for postgraduate critical care trainees. The systematic approach outlined can significantly reduce diagnostic delays and improve patient outcomes in this high-stakes clinical scenario.

Keywords: mechanical ventilation, desaturation, DOPE mnemonic, critical care, respiratory failure


Introduction

Acute desaturation in mechanically ventilated patients is among the most urgent scenarios encountered in intensive care units, with potential for rapid clinical deterioration if not promptly addressed¹. The incidence of ventilator-associated complications ranges from 5-15% of all mechanically ventilated patients, with acute desaturation episodes occurring in up to 25% of patients during their ICU stay²,³. The etiology is diverse, ranging from simple equipment malfunction to life-threatening conditions such as tension pneumothorax or massive pulmonary embolism.

The challenge for clinicians lies in the need for rapid, systematic assessment while simultaneously providing supportive care. Unlike spontaneously breathing patients, ventilated patients cannot compensate through increased respiratory effort, making immediate intervention crucial⁴. This review provides a structured approach to acute desaturation using the validated DOPE framework, emphasizing bedside assessment techniques and immediate management strategies.

The DOPE Mnemonic: A Systematic Framework

The DOPE mnemonic has emerged as the gold standard for systematic evaluation of acute desaturation in ventilated patients⁵,⁶. Originally developed for neonatal resuscitation, its application has been successfully extended to adult critical care with excellent diagnostic accuracy⁷.

D - Displacement

Definition: Malposition of the endotracheal tube resulting in inadequate ventilation.

Types of Displacement:

  • Esophageal intubation: Complete displacement into the esophagus
  • Right mainstem intubation: Advancement beyond the carina, typically into the right main bronchus
  • Partial extubation: Tube positioned at or above the vocal cords

Clinical Recognition: The classic triad for esophageal intubation includes absent breath sounds, gastric distension, and lack of chest rise⁸. However, in obese patients or those with significant subcutaneous emphysema, these signs may be subtle.

๐Ÿ” Clinical Pearl: In patients with sudden, severe desaturation and loss of ETCO₂ waveform, consider complete tube displacement first. The absence of condensation in the endotracheal tube during exhalation is an early visual cue.

Immediate Assessment:

  1. Visual inspection: Check tube position at the lips (typically 21-23 cm in average adults)
  2. Auscultation: Bilateral breath sounds assessment
  3. Capnography: Loss of ETCO₂ waveform suggests esophageal position
  4. Direct laryngoscopy: If available and expertise permits

Management:

  • If displacement is confirmed or highly suspected, immediate reintubation is indicated
  • Pre-oxygenate with bag-mask ventilation if possible
  • Consider emergency surgical airway if reintubation fails

O - Obstruction

Definition: Blockage of airflow through the endotracheal tube or major airways.

Common Causes:

  • Secretion plugging: Most common cause, especially in patients with thick secretions⁹
  • Blood clots: Following airway trauma or bleeding
  • Tube kinking: External compression or patient positioning
  • Foreign body aspiration: Including dental work, food particles, or medical devices

Clinical Presentation: Obstruction typically presents with high peak airway pressures (>40 cmH₂O), difficulty with manual ventilation, and progressive hypoxemia¹⁰. Unlike displacement, capnography may show diminished but present ETCO₂.

๐Ÿ” Clinical Pearl: The "squeeze test" - inability to manually compress the ventilation bag suggests significant obstruction. Normal squeeze with high ventilator pressures points to ventilator malfunction.

Bedside Assessment Techniques:

  1. Manual ventilation test: Disconnect from ventilator and attempt bag ventilation
  2. Suction assessment: Pass suction catheter to full depth of tube
  3. Peak pressure analysis: Sudden increase suggests acute obstruction
  4. Tube manipulation: Gentle rotation may dislodge soft obstructions

Management Strategy:

  • Immediate suctioning: Use closed-suction system initially, then open if necessary
  • Bronchodilator administration: Nebulized bronchodilators for bronchospasm
  • Tube replacement: If obstruction cannot be cleared
  • Emergency bronchoscopy: For complex obstructions or foreign bodies

๐Ÿ” Oyster (Common Pitfall): Don't assume all high pressures are due to obstruction. Patient-ventilator dyssynchrony, pneumothorax, and pulmonary edema can also increase peak pressures.

P - Pneumothorax

Definition: Accumulation of air in the pleural space, potentially causing lung collapse and hemodynamic compromise.

Risk Factors in Ventilated Patients:

  • High positive end-expiratory pressure (PEEP) >10 cmH₂O¹¹
  • Peak inspiratory pressures >30 cmH₂O
  • Recent central line insertion
  • Pre-existing lung disease (COPD, asthma, ARDS)
  • Barotrauma from aggressive ventilation¹²

Clinical Presentation: The classic presentation includes sudden onset hypoxemia, hypotension, increased peak pressures, and diminished breath sounds on the affected side¹³. However, in ventilated patients, the presentation may be subtle.

๐Ÿ” Clinical Pearl: In ventilated patients, the first sign of pneumothorax is often an increase in peak airway pressures before hypoxemia develops. Monitor pressure trends closely.

Rapid Bedside Assessment:

  1. Auscultation: Diminished or absent breath sounds
  2. Percussion: Hyperresonance on affected side
  3. Tactile fremitus: Reduced on affected side
  4. Visual inspection: Asymmetric chest expansion
  5. Ultrasound: Absence of lung sliding and presence of lung point¹⁴

Immediate Management:

  • Tension pneumothorax: Immediate needle decompression at 2nd intercostal space, midclavicular line
  • Simple pneumothorax: Consider chest tube placement depending on size
  • Bilateral pneumothorax: Life-threatening emergency requiring bilateral decompression

๐Ÿ” Clinical Hack: The "coin test" - place a coin on the chest and percuss. In pneumothorax, the coin produces a distinctive metallic sound (Hamman's sign).

E - Equipment Failure

Definition: Malfunction of ventilator components, monitoring devices, or associated equipment affecting ventilation delivery.

Common Equipment Failures:

  • Ventilator malfunction: Circuit leaks, valve failures, software errors¹⁵
  • Oxygen supply issues: Empty tanks, pipeline failures, flow meter problems
  • Circuit problems: Disconnections, leaks, water accumulation
  • Monitoring failures: Pulse oximetry artifacts, capnography malfunctions

Systematic Equipment Check:

  1. Ventilator display: Check for alarms, error messages, and parameter delivery
  2. Circuit integrity: Inspect for disconnections, cracks, or kinks
  3. Oxygen source: Verify oxygen supply and concentration
  4. Monitoring equipment: Confirm pulse oximetry signal quality and capnography waveform

๐Ÿ” Clinical Pearl: Always have a manual resuscitation bag readily available. When in doubt about equipment function, switch to manual ventilation while troubleshooting.

Management Approach:

  • Immediate manual ventilation: While assessing equipment
  • Circuit replacement: If leak or malfunction suspected
  • Ventilator change: Switch to backup ventilator if primary unit fails
  • Alternative monitoring: Use multiple modalities to confirm patient status

Bedside Stepwise Troubleshooting Protocol

Phase 1: Immediate Assessment (0-2 minutes)

Primary Survey:

  1. Patient responsiveness: Check for signs of distress, consciousness level
  2. Vital signs: Heart rate, blood pressure, oxygen saturation trend
  3. Ventilator parameters: Peak pressures, tidal volumes, oxygen delivery
  4. Visual inspection: Tube position, circuit integrity, chest expansion

๐Ÿ” Clinical Hack: The "30-second rule" - spend no more than 30 seconds on initial assessment before beginning interventions. Time is critical in severe desaturation.

Phase 2: DOPE Assessment (2-5 minutes)

Execute systematic DOPE evaluation as outlined above, proceeding through each component methodically while providing supportive care.

Phase 3: Advanced Evaluation (5-15 minutes)

If initial DOPE assessment is negative:

  • Cardiovascular assessment: Signs of right heart strain, arrhythmias
  • Neurological evaluation: Sedation level, respiratory drive
  • Metabolic considerations: Temperature, glucose, electrolytes
  • Infectious causes: Signs of ventilator-associated pneumonia

Phase 4: Diagnostic Confirmation (15+ minutes)

Imaging Studies:

  • Chest X-ray: First-line imaging for tube position, pneumothorax, infiltrates
  • CT chest: For complex cases or when chest X-ray is non-diagnostic¹⁶
  • Echocardiography: Assess for pulmonary embolism, right heart failure

Laboratory Studies:

  • Arterial blood gas: Definitive assessment of oxygenation and ventilation
  • Complete blood count: Hemoglobin level, white blood cell count
  • D-dimer and troponin: If pulmonary embolism or cardiac causes suspected

Immediate Actions Before ABG Analysis

The "ABC" Approach to Pre-ABG Management

A - Airway Security

  • Verify endotracheal tube position and patency
  • Ensure adequate tube cuff pressure (20-30 cmH₂O)
  • Clear secretions with suctioning

B - Breathing Support

  • Increase FiO₂ to 100% temporarily
  • Consider increasing PEEP in increments of 2-5 cmH₂O
  • Adjust ventilator mode if patient-ventilator dyssynchrony suspected

C - Circulation Support

  • Ensure adequate intravascular volume
  • Consider vasopressor support if hypotensive
  • Monitor for signs of hemodynamic compromise

๐Ÿ” Clinical Pearl: The "Rule of 100" - Increase FiO₂ to 100% and PEEP by 5 cmH₂O as initial temporizing measures while investigating the underlying cause. This buys time for systematic evaluation.

Pharmacological Interventions

Bronchodilator Therapy:

  • Albuterol: 2.5-5 mg nebulized every 20 minutes for bronchospasm
  • Ipratropium: 0.5 mg nebulized for refractory bronchospasm
  • Systemic steroids: Consider methylprednisolone 1-2 mg/kg for severe bronchospasm

Sedation and Paralysis:

  • Adequate sedation: Ensure patient comfort and ventilator synchrony
  • Neuromuscular blockade: Consider for severe dyssynchrony or high airway pressures¹⁷
  • Analgesics: Address pain-related agitation

Monitoring Enhancements

Advanced Monitoring:

  • Capnography: Continuous ETCO₂ monitoring for ventilation assessment
  • Esophageal pressure monitoring: In complex ARDS cases
  • Transpulmonary pressure: For PEEP optimization
  • Mixed venous oxygen saturation: Assessment of oxygen delivery

Clinical Pearls and Expert Insights

Diagnostic Pearls

๐Ÿ” Pearl 1 - The "Differential Desaturation" Sign: Unequal oxygen saturation readings between different extremities may suggest arterial line positioning issues or peripheral vascular disease rather than true pulmonary pathology.

๐Ÿ” Pearl 2 - The "Silent Pneumothorax": In patients on high PEEP, small pneumothoraces may not cause immediate pressure changes. Watch for subtle increases in peak pressures over time.

๐Ÿ” Pearl 3 - The "Position Test": If desaturation improves with patient repositioning, consider atelectasis, pleural effusion, or unilateral lung pathology.

Management Pearls

๐Ÿ” Pearl 4 - The "Trial of PEEP": A trial increase in PEEP of 5 cmH₂O can rapidly distinguish between atelectasis (improvement) and pneumothorax (worsening).

๐Ÿ” Pearl 5 - The "Recruitment Maneuver": Sustained inflations (30-40 cmH₂O for 30 seconds) can rapidly improve oxygenation in atelectatic lungs but should be used cautiously¹⁸.

Common Oysters (Pitfalls)

๐Ÿšจ Oyster 1 - The "Normal ABG Trap": Normal arterial blood gas values don't rule out serious pathology. A patient with baseline hypoxemia may have a "normal" PaO₂ despite significant clinical deterioration.

๐Ÿšจ Oyster 2 - The "Equipment Bias": Over-reliance on monitoring equipment without clinical correlation. Always correlate pulse oximetry with clinical appearance and other vital signs.

๐Ÿšจ Oyster 3 - The "Single Parameter Focus": Focusing solely on oxygen saturation while ignoring ventilation (ETCO₂) and hemodynamics can lead to missed diagnoses.

Advanced Troubleshooting Techniques

The "Ventilator Liberation" Test

Technique: Temporarily disconnect the patient from the ventilator and provide manual bag ventilation with 100% oxygen.

Interpretation:

  • Improvement with bagging: Suggests ventilator malfunction
  • No improvement: Points to patient-related factors
  • Worsening: May indicate need for higher pressures or specific ventilator modes

The "Differential Ventilation" Assessment

For Suspected Unilateral Pathology:

  1. Temporarily clamp one side of a double-lumen tube or bronchial blocker
  2. Assess improvement in oxygenation
  3. Identifies which lung is contributing to hypoxemia

Ultrasonographic Assessment

Lung Ultrasound Protocol:

  1. Anterior chest: Assess for pneumothorax (lung sliding)
  2. Lateral chest: Evaluate for consolidation or effusion
  3. Posterior chest: Check for dependent atelectasis
  4. Cardiac assessment: Right heart strain, fluid status

๐Ÿ” Clinical Hack: The "BLUE protocol" (Bedside Lung Ultrasonography in Emergency) can be completed in under 3 minutes and has excellent diagnostic accuracy for common causes of acute respiratory failure¹⁹.

Evidence-Based Management Strategies

Oxygenation Optimization

PEEP Titration Strategies:

  • Best compliance method: Titrate PEEP to maximum static compliance²⁰
  • Oxygenation method: Increase PEEP until FiO₂ can be reduced to <0.6
  • Esophageal pressure guidance: Maintain transpulmonary pressure 0-10 cmH₂O

Prone Positioning: Consider for patients with PaO₂/FiO₂ ratio <150 mmHg despite optimal PEEP. Improvement often seen within 1-2 hours²¹.

Ventilation Strategies

Lung-Protective Ventilation:

  • Tidal volume: 6-8 mL/kg predicted body weight
  • Plateau pressure: <30 cmH₂O
  • Driving pressure: <15 cmH₂O (emerging evidence)²²

Alternative Ventilation Modes:

  • Airway pressure release ventilation (APRV): For severe ARDS
  • High-frequency oscillatory ventilation: Rescue therapy for refractory hypoxemia
  • Extracorporeal membrane oxygenation (ECMO): Ultimate rescue therapy²³

Quality Improvement and Safety Considerations

Checklist Implementation

The "Desaturation Response Checklist": □ Manual ventilation initiated □ DOPE assessment completed □ FiO₂ increased to 100% □ Suction performed □ Chest examination completed □ Equipment check performed □ Senior clinician notified □ ABG ordered □ Chest X-ray ordered (if indicated) □ Response documented

Error Prevention Strategies

Common Cognitive Biases:

  • Anchoring bias: Fixating on initial impression without considering alternatives
  • Confirmation bias: Seeking only information that confirms initial diagnosis
  • Availability heuristic: Overestimating likelihood of recently encountered conditions

Mitigation Strategies:

  • Use systematic approaches like DOPE
  • Encourage differential thinking
  • Implement timeout procedures for complex cases
  • Regular case reviews and learning from near-misses

Future Directions and Emerging Technologies

Artificial Intelligence Applications

Machine Learning in Ventilator Management:

  • Predictive algorithms for ventilator weaning²⁴
  • Real-time optimization of ventilator parameters
  • Early warning systems for clinical deterioration

Automated Monitoring Systems:

  • Continuous monitoring of compliance and resistance
  • Automatic adjustment of ventilator parameters
  • Integration with electronic health records for decision support

Novel Monitoring Technologies

Advanced Gas Exchange Monitoring:

  • Volumetric capnography for dead space calculation
  • Continuous monitoring of oxygen consumption
  • Real-time assessment of ventilation-perfusion matching

Non-invasive Cardiac Output Monitoring:

  • Integration with ventilator data for comprehensive assessment
  • Trending of hemodynamic parameters
  • Early detection of cardiovascular compromise

Conclusion

Acute desaturation in mechanically ventilated patients requires rapid, systematic assessment and intervention. The DOPE mnemonic provides an effective framework for clinical evaluation, while bedside troubleshooting techniques enable prompt diagnosis and management. Key principles include immediate stabilization with increased FiO₂ and manual ventilation, systematic evaluation using the DOPE framework, and prompt correction of identified abnormalities.

Success in managing these critical scenarios depends on preparation, systematic approach, and recognition that time is critical. Regular simulation training, equipment familiarity, and adherence to evidence-based protocols can significantly improve patient outcomes. As technology advances, integration of artificial intelligence and advanced monitoring may further enhance our ability to rapidly diagnose and treat these challenging clinical scenarios.

The approach outlined in this review emphasizes practical, bedside techniques that can be immediately implemented by critical care practitioners. By combining systematic assessment with evidence-based interventions, clinicians can optimize outcomes for this high-risk patient population.


References

  1. Esteban A, Frutos-Vivar F, Muriel A, et al. Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med. 2013;188(2):220-230.

  2. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126-2136.

  3. Benรญtez-Cano A, Peรฑuelas O, Lorente JA, et al. Acute respiratory distress syndrome: A review of the Berlin definition. Rev Esp Anestesiol Reanim. 2014;61(6):319-327.

  4. Fan E, Del Sorbo L, Goligher EC, et al. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195(9):1253-1263.

  5. Kattwinkel J, Perlman JM, Aziz K, et al. Neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics. 2010;126(5):e1400-13.

  6. Leone M, Bouadma L, Bouhemad B, et al. Hospital-acquired pneumonia in ICU. Anaesth Crit Care Pain Med. 2018;37(1):83-98.

  7. Kelly FE, Cook TM. Seeing the light: Videolaryngoscopy improves intubation success. Br J Anaesth. 2016;117(1):6-8.

  8. Caplan RA, Posner KL, Ward RJ, Cheney FW. Adverse respiratory events in anesthesia: a closed claims analysis. Anesthesiology. 1990;72(5):828-833.

  9. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115-2121.

  10. Tobin MJ. Advances in mechanical ventilation. N Engl J Med. 2001;344(26):1986-1996.

  11. Gammon RB, Shin MS, Buchalter SE. Pulmonary barotrauma in mechanical ventilation. Patterns and risk factors. Chest. 1992;102(2):568-572.

  12. Anzueto A, Frutos-Vivar F, Esteban A, et al. Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients. Intensive Care Med. 2004;30(4):612-619.

  13. Light RW. Pleural diseases. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.

  14. Lichtenstein DA. BLUE-protocol and FALLS-protocol: two applications of lung ultrasound in the critically ill. Chest. 2015;147(6):1659-1670.

  15. Branson RD, Johannigman JA. The measurement of ventilator-associated pneumonia: understanding the issues. Respir Care. 2004;49(10):1213-1221.

  16. Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med. 2006;354(17):1775-1786.

  17. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107-1116.

  18. Hodgson C, Goligher EC, Young ME, et al. Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation. Cochrane Database Syst Rev. 2016;11:CD006667.

  19. Lichtenstein DA, Meziรจre GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol. Chest. 2008;134(1):117-125.

  20. Suarez-Sipmann F, Bรถhm SH, Tusman G, et al. Use of dynamic compliance for open lung positive end-expiratory pressure titration in an experimental study. Crit Care Med. 2007;35(1):214-221.

  21. Guรฉrin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159-2168.

  22. Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747-755.

  23. Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(21):1965-1975.

  24. Bialais E, Wittebole X, Vignaux L, et al. Closed-loop ventilation mode reduces ventilation heterogeneity in the early phase of acute respiratory distress syndrome: a randomized crossover study. Anesthesiology. 2016;125(2):333-342.


Conflicts of Interest: None declared

Funding: No specific funding received for this review


Ventilator Basics for the First On-Call Resident

Ventilator Basics for the First On-Call Resident: A Practical Guide for Critical Care Trainees

Dr Neeraj Manikath , claude.ai

Abstract

Background: Mechanical ventilation is a cornerstone of critical care medicine, yet many residents feel underprepared when first encountering ventilated patients during on-call duties. This review provides a practical, evidence-based approach to understanding ventilator modes, settings, and troubleshooting for novice critical care practitioners.

Objective: To equip first-year critical care residents with essential knowledge for safe and effective mechanical ventilation management during independent on-call periods.

Methods: This review synthesizes current evidence-based practices, expert consensus guidelines, and practical clinical experience to provide actionable guidance for ventilator management.

Results: Key areas covered include fundamental ventilator modes (VCV, PCV, SIMV, PSV), pathology-specific ventilator settings, systematic alarm troubleshooting, and clear escalation criteria.

Conclusions: A structured approach to mechanical ventilation, combined with knowledge of when to seek senior support, can significantly improve patient safety and resident confidence during critical care rotations.

Keywords: mechanical ventilation, critical care, medical education, resident training, ventilator modes


Introduction

Mechanical ventilation represents one of the most complex and high-stakes interventions in critical care medicine. For the first-time on-call resident, the ventilator can appear as an intimidating array of numbers, alarms, and modes. However, with a systematic approach and understanding of fundamental principles, mechanical ventilation becomes a powerful therapeutic tool rather than a source of anxiety.

This review aims to provide practical, evidence-based guidance specifically tailored for residents in their first critical care rotations. The focus is on safety, systematic thinking, and knowing one's limitations—principles that form the foundation of excellent critical care practice.


Fundamental Ventilator Modes

Volume-Controlled Ventilation (VCV)

Volume-controlled ventilation delivers a preset tidal volume with each breath, making it the most predictable mode for ensuring adequate ventilation.

Mechanism: The ventilator delivers a set tidal volume regardless of airway pressures, though safety pressure limits prevent barotrauma.

Key Parameters:

  • Tidal Volume (Vt): 6-8 mL/kg ideal body weight for most patients
  • Respiratory Rate (RR): Typically 12-20 breaths/minute
  • PEEP: Usually 5-8 cmH₂O initially
  • FiO₂: Start at 0.4-0.6, titrate to SpO₂ 88-95%

Clinical Pearl: VCV is your "training wheels" mode. The consistent tidal volume makes it easier to predict CO₂ elimination and is forgiving of minor setting adjustments.

Advantages:

  • Guaranteed minute ventilation
  • Predictable CO₂ elimination
  • Easy to calculate ventilator settings

Disadvantages:

  • Variable airway pressures
  • Less comfortable for awake patients
  • Risk of barotrauma if compliance changes

Pressure-Controlled Ventilation (PCV)

PCV delivers breaths to a preset inspiratory pressure, allowing tidal volumes to vary based on lung compliance and airway resistance.

Mechanism: The ventilator achieves a target inspiratory pressure, with tidal volume determined by the pressure gradient and lung mechanics.

Key Parameters:

  • Inspiratory Pressure (Pinsp): Usually 15-25 cmH₂O above PEEP
  • I:E Ratio: Typically 1:2 to 1:3
  • PEEP: 5-15 cmH₂O depending on pathology
  • Respiratory Rate: 12-25 breaths/minute

Clinical Hack: Think "PEEP + Driving Pressure = Pinsp." For most patients, start with a driving pressure of 15-20 cmH₂O.

Advantages:

  • Controlled peak airway pressures
  • Better patient comfort
  • Improved gas distribution in heterogeneous lung disease

Disadvantages:

  • Variable tidal volumes
  • Requires more monitoring
  • Minute ventilation changes with lung mechanics

Synchronized Intermittent Mandatory Ventilation (SIMV)

SIMV provides mandatory breaths synchronized with patient effort, while allowing spontaneous breathing between mandatory breaths.

Mechanism: The ventilator delivers a set number of mandatory breaths but allows the patient to breathe spontaneously with or without pressure support.

Clinical Application:

  • Weaning mode primarily
  • Allows gradual transition to spontaneous breathing
  • Can be combined with pressure support

Oyster Alert: SIMV can be a trap for inexperienced users. Patients may "fight" the ventilator if mandatory rate is too high, or develop respiratory muscle fatigue if too low. When in doubt, switch to full support modes.

Pressure Support Ventilation (PSV)

PSV assists every spontaneous breath with a preset pressure, allowing the patient to control timing and tidal volume.

Mechanism: Patient-triggered, pressure-limited, flow-cycled breaths that augment spontaneous respiratory effort.

Key Parameters:

  • Pressure Support Level: Usually 5-15 cmH₂O
  • PEEP: 5-8 cmH₂O typically
  • Flow termination: Usually 25% of peak flow

Clinical Pearl: PSV is excellent for weaning, but requires an awake, cooperative patient with adequate respiratory drive. Never use PSV in deeply sedated patients.


Pathology-Specific Ventilator Settings

Acute Respiratory Distress Syndrome (ARDS)

ARDS requires lung-protective ventilation strategies based on the ARDSNet protocol.

Evidence-Based Settings:

  • Mode: VCV or PCV
  • Tidal Volume: 6 mL/kg ideal body weight (4-8 mL/kg range)
  • Plateau Pressure: Keep ≤30 cmH₂O
  • PEEP: Use PEEP/FiO₂ table (typically 10-15 cmH₂O)
  • FiO₂: Target SpO₂ 88-95% or PaO₂ 55-80 mmHg

Clinical Hack: For quick ARDS setup: Start with Vt 6 mL/kg IBW, PEEP 10, FiO₂ 0.6, RR 20. Check plateau pressure immediately.

Chronic Obstructive Pulmonary Disease (COPD)

COPD patients require strategies to minimize air trapping and auto-PEEP.

Key Strategies:

  • Tidal Volume: 6-8 mL/kg (may need higher for chronic CO₂ retainers)
  • Respiratory Rate: Lower (8-12) to allow expiration
  • I:E Ratio: 1:3 or 1:4 to maximize expiratory time
  • PEEP: Low (3-5 cmH₂O) or intrinsic PEEP level

Clinical Pearl: The COPD mantra: "Low and slow." Lower respiratory rates with longer expiratory times prevent breath stacking.

Status Asthmaticus

Similar to COPD but often requires more aggressive bronchodilation and sometimes permissive hypercapnia.

Settings:

  • Mode: VCV or PCV
  • Respiratory Rate: 8-10 to maximize expiratory time
  • I:E Ratio: 1:4 or 1:5
  • Tidal Volume: 6-8 mL/kg
  • Plateau Pressure: May accept up to 35 cmH₂O

Cardiogenic Pulmonary Edema

Focus on reducing preload and afterload while supporting oxygenation.

Settings:

  • PEEP: Higher levels (10-15 cmH₂O) improve oxygenation
  • Tidal Volume: 6-8 mL/kg
  • FiO₂: Titrate to adequate oxygenation
  • Consider: BiPAP if patient is awake and cooperative

Systematic Alarm Troubleshooting

High Pressure Alarms

Immediate Assessment (ABC approach):

  1. Airway: Check ET tube position, suction for secretions
  2. Breathing: Listen for wheeze, assess chest rise
  3. Circuit: Inspect for kinks, water, disconnections

Common Causes and Solutions:

  • Secretions: Suction airway, consider bronchoscopy
  • Bronchospasm: Bronchodilators, consider steroids
  • Pneumothorax: Clinical examination, chest X-ray, consider needle decompression
  • Patient-ventilator dysynchrony: Assess sedation, consider mode change

Clinical Hack: The "30-Second Rule": If high-pressure alarm is sustained and patient appears distressed, disconnect from ventilator and bag manually while troubleshooting.

Low Pressure/Disconnection Alarms

Immediate Actions:

  1. Check all connections visually
  2. Assess chest rise and air entry
  3. Verify ET tube position

Common Causes:

  • Circuit disconnection
  • ET tube migration or cuff leak
  • Massive air leak (bronchopleural fistula)
  • Ventilator malfunction

Low Tidal Volume Alarms

Assessment Priority:

  • Check patient effort and respiratory drive
  • Assess lung compliance changes
  • Verify ventilator settings

Common in:

  • Worsening lung compliance
  • Patient fatigue
  • Sedation changes
  • Circuit leaks

When to Call for Help: Clear Escalation Criteria

Immediate Senior Consultation (Call Now):

  1. Hemodynamic instability related to ventilator changes
  2. Refractory hypoxemia (SpO₂ <88% despite FiO₂ >0.8 and PEEP >15)
  3. Suspected pneumothorax with hemodynamic compromise
  4. Persistent patient-ventilator dysynchrony despite adjustments
  5. Any situation where you feel uncomfortable making ventilator changes

Urgent Consultation (Within 30 minutes):

  1. Plateau pressures >30 cmH₂O requiring ARDS protocol adjustments
  2. Auto-PEEP >10 cmH₂O in COPD/asthma patients
  3. Difficulty weaning established patients
  4. New chest X-ray findings suggesting complications

Routine Consultation (Next rounds):

  1. Stable patients requiring mode changes
  2. Weaning readiness assessment
  3. Ventilator setting optimization

Golden Rule: "When in doubt, ask." It's better to be seen as cautious than to miss a critical change. Senior colleagues would rather be called unnecessarily than deal with a preventable complication.


Practical Pearls and Clinical Hacks

The "DOPE" Mnemonic for Acute Deterioration:

  • Disconnection/displacement
  • Obstruction (secretions, kink)
  • Pneumothorax
  • Equipment failure

Essential Daily Ventilator Checks:

  1. Mode and basic settings match orders
  2. Plateau pressure <30 cmH₂O (if applicable)
  3. Auto-PEEP measurement in COPD/asthma
  4. Cuff pressure 20-25 cmH₂O
  5. Weaning readiness assessment

Quick Setting Calculations:

  • Ideal Body Weight (Male): 50 + 2.3 × (height in inches - 60)
  • Ideal Body Weight (Female): 45.5 + 2.3 × (height in inches - 60)
  • Minute Ventilation: Tidal Volume × Respiratory Rate
  • Driving Pressure: Plateau Pressure - PEEP

Communication Pearls:

  • Always state: Patient name, current mode, and your concern
  • Use SBAR format: Situation, Background, Assessment, Recommendation
  • Have ready: Recent ABG, chest X-ray findings, vital signs

Evidence-Based Guidelines and Protocols

ARDSNet Protocol Summary:

  • Target Vt: 6 mL/kg IBW
  • Target plateau pressure: ≤30 cmH₂O
  • PEEP/FiO₂ combinations per protocol table
  • pH goal: 7.30-7.45
  • SpO₂ goal: 88-95%

Weaning Protocol Principles:

  1. Daily sedation interruption and spontaneous breathing trial
  2. Assess readiness: FiO₂ ≤0.4, PEEP ≤8, minimal vasopressors
  3. SBT parameters: PSV 5-8 cmH₂O, PEEP 5, 30-120 minutes
  4. Success criteria: RR <35, SpO₂ >90%, stable hemodynamics

Common Pitfalls and How to Avoid Them

Pitfall 1: Chasing Numbers Instead of Treating the Patient

Avoidance Strategy: Always correlate ventilator parameters with clinical status. A patient who looks comfortable with "abnormal" numbers may be stable.

Pitfall 2: Making Multiple Changes Simultaneously

Avoidance Strategy: Change one parameter at a time and assess response before making additional adjustments.

Pitfall 3: Ignoring Auto-PEEP in Obstructive Disease

Avoidance Strategy: Always check expiratory flow waveforms and measure auto-PEEP in COPD/asthma patients.

Pitfall 4: Inadequate Sedation Assessment

Avoidance Strategy: Use validated sedation scales and assess patient-ventilator synchrony regularly.


Quality Improvement and Safety Measures

Daily Checklist Items:

  • [ ] Ventilator settings match physician orders
  • [ ] Appropriate alarms are set and functional
  • [ ] Sedation score documented and appropriate
  • [ ] Weaning assessment completed
  • [ ] Family communication documented

Safety Protocols:

  1. Always verify patient identity before making changes
  2. Double-check calculations with nursing staff
  3. Document all changes with rationale
  4. Reassess patient within 15-30 minutes after changes

Conclusion

Mechanical ventilation mastery develops through systematic learning, careful observation, and graduated responsibility. The foundation of safe practice lies not in memorizing every possible scenario, but in understanding basic principles, maintaining situational awareness, and knowing when to seek guidance from experienced colleagues.

Remember that every expert was once a beginner. The key to growth in critical care is maintaining intellectual humility while building clinical confidence through structured learning and supervised practice. Your patients benefit most from a resident who thinks systematically, communicates clearly, and isn't afraid to ask for help when needed.

The ventilator is a powerful tool, but it is your clinical judgment, careful monitoring, and thoughtful decision-making that ultimately determine patient outcomes. Approach each shift with preparation, vigilance, and the knowledge that you are part of a team committed to excellent patient care.


References

  1. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308.

  2. Brochard L, Rauss A, Benito S, et al. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. Am J Respir Crit Care Med. 1994;150(4):896-903.

  3. Esteban A, Frutos F, Tobin MJ, et al. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med. 1995;332(6):345-350.

  4. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126-134.

  5. Putensen C, Zech S, Wrigge H, et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med. 2001;164(1):43-49.

  6. Tobin MJ. Principles and Practice of Mechanical Ventilation. 3rd ed. New York, NY: McGraw-Hill; 2013.

  7. Pilbeam SP, Cairo JM. Mechanical Ventilation: Physiological and Clinical Applications. 5th ed. St. Louis, MO: Mosby Elsevier; 2012.

  8. MacIntyre NR, Epstein SK, Carson S, et al. Management of patients requiring prolonged mechanical ventilation: report of a NAMDRC consensus conference. Chest. 2005;128(6):3937-3954.

  9. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126-2136.

  10. Kacmarek RM, Stoller JK, Heuer AJ. Egan's Fundamentals of Respiratory Care. 11th ed. St. Louis, MO: Elsevier; 2017.

  11. Hess DR. Respiratory mechanics in mechanically ventilated patients. Respir Care. 2014;59(11):1773-1794.

  12. Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020;323(22):2329-2330.

  13. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107-1116.

  14. Guรฉrin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159-2168.

  15. Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747-755.


Conflicts of Interest: The authors declare no conflicts of interest.

Funding: No specific funding was received for this work.

Ethics: Not applicable for this review article.

Oxygen Delivery Devices in the ICU – Choosing the Right One

 

Oxygen Delivery Devices in the ICU – Choosing the Right One: A Comprehensive Review for Critical Care Practitioners

Dr Neeraj Manikath , claude.ai

Abstract

Background: Appropriate oxygen delivery is fundamental to critical care management, yet the selection of optimal devices remains challenging. With expanding options from simple nasal cannulae to advanced high-flow nasal cannula (HFNC) systems, clinicians must understand the nuances of each modality.

Objective: To provide a comprehensive review of oxygen delivery devices available in the ICU setting, focusing on practical selection criteria, physiological considerations, and evidence-based transitions between devices.

Methods: Narrative review of current literature, clinical guidelines, and expert consensus on oxygen delivery modalities in critical care.

Results: Six primary oxygen delivery systems are analyzed: nasal cannula, Venturi masks, non-rebreather masks, HFNC, non-invasive ventilation (NIV), and invasive mechanical ventilation. Each device offers distinct advantages with specific indications, flow rate capabilities, and FiO₂ delivery ranges.

Conclusions: Strategic device selection and timely transitions optimize patient outcomes while minimizing complications. Understanding physiological principles and practical limitations guides evidence-based oxygen therapy decisions.

Keywords: Oxygen therapy, Critical care, Respiratory failure, High-flow nasal cannula, Non-invasive ventilation


Introduction

Oxygen therapy represents one of the most fundamental interventions in critical care medicine, yet its optimal delivery remains a complex clinical decision. The landscape of oxygen delivery devices has evolved significantly, with traditional low-flow systems now complemented by sophisticated high-flow and pressure-support technologies¹. The choice of appropriate oxygen delivery device can significantly impact patient outcomes, comfort, and resource utilization.

Recent advances in oxygen delivery technology, particularly high-flow nasal cannula (HFNC) systems, have challenged traditional stepwise approaches to respiratory support². However, each device maintains specific advantages and limitations that must be understood within the context of individual patient physiology and clinical scenarios.

This review provides critical care practitioners with an evidence-based framework for oxygen device selection, emphasizing practical considerations, physiological rationale, and optimal transition strategies between modalities.


Physiological Principles of Oxygen Delivery

Oxygen Transport and Delivery

Effective oxygen therapy requires understanding the oxygen cascade from atmospheric air to cellular utilization. Key factors influencing oxygen delivery include:

  • Fraction of inspired oxygen (FiO₂): The percentage of oxygen in inspired gas
  • Respiratory system mechanics: Compliance, resistance, and work of breathing
  • Ventilation-perfusion matching: Optimization of gas exchange efficiency
  • Cardiac output: Oxygen transport to tissues
  • Hemoglobin concentration and affinity: Oxygen carrying capacity³

Dead Space Considerations

Different oxygen delivery devices impact anatomical and physiological dead space differently. High-flow systems can provide dead space washout, improving ventilation efficiency, while low-flow systems may increase rebreathing of expired gases⁴.


Device Categories and Specifications

1. Nasal Cannula (NC)

Flow Rates: 1-6 L/min FiO₂ Range: 24-44% Delivered FiO₂ Formula: FiO₂ ≈ 21% + (4% × flow rate in L/min)

Advantages:

  • Comfortable and well-tolerated
  • Allows eating, drinking, and speaking
  • Cost-effective
  • Minimal dead space
  • Easy application and monitoring

Limitations:

  • Variable FiO₂ delivery dependent on patient's respiratory pattern
  • Limited to low oxygen concentrations
  • Ineffective with mouth breathing
  • Drying of nasal mucosa at higher flows
  • No humidification capability

Pearl: The "4% rule" provides a rough estimate, but actual FiO₂ varies significantly with respiratory rate, tidal volume, and breathing pattern⁵.

2. Venturi Masks (VM)

Flow Rates: Device-specific (typically 2-15 L/min) FiO₂ Range: 24%, 28%, 31%, 35%, 40%, 60% Mechanism: Fixed-performance device using Venturi principle

Advantages:

  • Precise, reliable FiO₂ delivery
  • Performance independent of respiratory pattern
  • Built-in entrainment ratios ensure consistency
  • Immediate availability and simple setup
  • Cost-effective for controlled oxygen delivery

Limitations:

  • Limited FiO₂ options (discrete settings)
  • Claustrophobic for some patients
  • Interferes with eating and communication
  • Requires specific flow rates for each FiO₂
  • May not meet high minute ventilation demands

Hack: Always verify the correct flow rate is set for the desired FiO₂ – this is the most common error with Venturi masks⁶.

3. Non-Rebreather Mask (NRBM)

Flow Rates: 10-15 L/min (minimum 10 L/min to prevent bag collapse) FiO₂ Range: 60-95% (theoretical), 60-80% (practical)

Advantages:

  • High FiO₂ delivery capability
  • Reservoir bag stores oxygen for inspiration
  • One-way valves prevent rebreathing
  • Useful for acute hypoxemia
  • Rapid oxygen delivery escalation

Limitations:

  • Variable FiO₂ depending on mask fit and respiratory pattern
  • Requires adequate flow to prevent bag collapse
  • Claustrophobic and uncomfortable
  • Impedes communication and oral intake
  • Risk of CO₂ retention in some patients
  • Disposable and single-use only

Oyster: Despite the name, some rebreathing occurs due to imperfect valve function and mask leak – actual delivered FiO₂ is typically 60-80%⁷.

4. High-Flow Nasal Cannula (HFNC)

Flow Rates: 20-70 L/min (adults) FiO₂ Range: 21-100% Temperature: 37°C with 44 mg/L absolute humidity

Physiological Effects:

  • Dead space washout
  • Positive end-expiratory pressure (PEEP) effect (2-8 cmH₂O)
  • Reduced work of breathing
  • Improved secretion clearance
  • Enhanced patient comfort⁸

Advantages:

  • Precise FiO₂ control across full range
  • Excellent patient tolerance and comfort
  • Allows normal activities (eating, speaking)
  • Warmed and humidified gas delivery
  • Reduces intubation rates in selected patients
  • Supports post-extubation respiratory failure
  • Facilitates weaning from mechanical ventilation

Limitations:

  • Higher cost compared to conventional devices
  • Requires specialized equipment and setup
  • May mask deteriorating respiratory status
  • Limited in severe hypercapnic respiratory failure
  • Potential for delayed recognition of need for intubation
  • Noise from high-flow generator

Pearl: HFNC provides approximately 1 cmH₂O of PEEP per 10 L/min of flow, but this varies significantly between patients⁹.

5. Non-Invasive Ventilation (NIV)

Continuous Positive Airway Pressure (CPAP)

Pressure Range: 5-20 cmH₂O FiO₂ Range: 21-100%

Bilevel Positive Airway Pressure (BiPAP)

IPAP Range: 8-30 cmH₂O EPAP Range: 4-20 cmH₂O FiO₂ Range: 21-100%

Advantages:

  • Positive pressure support reduces work of breathing
  • Effective for acute cardiogenic pulmonary edema
  • Beneficial in COPD exacerbations with hypercapnia
  • May prevent intubation in selected patients
  • Adjustable pressure and FiO₂ settings
  • Can be used post-extubation

Limitations:

  • Patient tolerance issues (mask discomfort, claustrophobia)
  • Risk of aspiration
  • Hemodynamic compromise in some patients
  • Contraindicated in certain conditions (facial trauma, inability to protect airway)
  • Requires experienced staff for setup and monitoring
  • Potential for pressure-related skin breakdown

Hack: Start with low pressures and gradually titrate upward – patient tolerance is key to NIV success¹⁰.

6. Invasive Mechanical Ventilation

FiO₂ Range: 21-100% Ventilatory Modes: Multiple (Volume Control, Pressure Control, SIMV, PSV, APRV, etc.)

Indications:

  • Severe hypoxemic respiratory failure
  • Hypercapnic respiratory failure with altered mental status
  • Inability to protect airway
  • Hemodynamic instability
  • Failed non-invasive approaches
  • Need for deep sedation or paralysis

Advantages:

  • Complete control over ventilation parameters
  • Airway protection
  • Ability to provide high PEEP and recruitment maneuvers
  • Supports patients during hemodynamic instability
  • Enables precise minute ventilation control
  • Facilitates bronchial hygiene

Limitations:

  • Invasive procedure with associated risks
  • Requires sedation and often paralysis
  • Ventilator-associated complications (VAP, VILI)
  • ICU resource intensive
  • Prolonged weaning process
  • Psychological impact on patients and families

Evidence-Based Selection Criteria

Clinical Scenarios and Device Selection

Mild Hypoxemia (PaO₂/FiO₂ > 300)

  • First-line: Nasal cannula or Venturi mask
  • Considerations: Patient comfort, precision requirements
  • Monitoring: SpO₂ and patient tolerance

Moderate Hypoxemia (PaO₂/FiO₂ 200-300)

  • First-line: HFNC or Venturi mask (high FiO₂)
  • Alternative: NRBM for acute presentations
  • Escalation pathway: NIV if failing conventional therapy

Severe Hypoxemia (PaO₂/FiO₂ < 200)

  • Initial: HFNC or NIV (if alert and cooperative)
  • Rapid escalation: Consider intubation if no improvement
  • Bridge therapy: HFNC post-extubation¹¹

Hypercapnic Respiratory Failure

  • First-line: NIV (BiPAP preferred)
  • Monitoring: Serial ABGs, mental status
  • Intubation criteria: pH < 7.25, altered consciousness, hemodynamic instability

Pearl: The ROX index (SpO₂/FiO₂ × respiratory rate) can help predict HFNC success – values > 4.88 at 12 hours suggest lower intubation risk¹².


Transition Strategies Between Devices

Escalation Pathways

NC → Venturi Mask/HFNC

Indications:

  • Increasing oxygen requirements (>6 L/min)
  • Need for precise FiO₂ control
  • Patient discomfort with high flows

Process:

  • Assess current oxygen saturation and comfort
  • Calculate required FiO₂ for target SpO₂ 88-92% (COPD) or 94-98% (other conditions)
  • Consider HFNC for improved comfort and potential clinical benefits

HFNC → NIV

Indications:

  • Persistent hypoxemia despite high FiO₂ (>60%)
  • Rising CO₂ levels
  • Increasing work of breathing
  • ROX index < 3.85 at 6 hours¹³

Process:

  • Ensure patient alertness and cooperation
  • Start with low pressures (IPAP 8-12, EPAP 4-6 cmH₂O)
  • Monitor for synchrony and comfort
  • Set clear failure criteria and timeline

NIV → Intubation

Indications:

  • Inability to maintain SpO₂ > 88% despite optimal settings
  • pH < 7.25 with rising CO₂
  • Hemodynamic instability
  • Decreased level of consciousness
  • Patient intolerance

De-escalation Strategies

Post-Extubation Support

  • First-line: HFNC (reduces reintubation rates)
  • Duration: Minimum 24-48 hours
  • Monitoring: Respiratory rate, work of breathing, gas exchange

Weaning from NIV

  • Gradual pressure reduction: Decrease IPAP by 2-4 cmH₂O increments
  • Trial periods: Progressive time off NIV with monitoring
  • Bridge to HFNC: Consider for continued support during weaning

Hack: Use the "30-minute rule" – if there's no improvement in respiratory distress within 30 minutes of escalating therapy, consider the next level of support¹⁴.


Pearls, Oysters, and Clinical Hacks

Pearls

  1. The "Oxygen Paradox": Higher FiO₂ isn't always better – target appropriate saturation ranges based on patient population
  2. Flow matters: In HFNC, flow rate is often more important than FiO₂ for patient comfort and physiological benefit
  3. Early recognition: Watch for subtle signs of failure before dramatic deterioration occurs

Oysters

  1. HFNC PEEP effect: Variable between patients and doesn't correlate linearly with flow rates
  2. Venturi accuracy: Performance depends on proper flow settings – commonly misconfigured in clinical practice
  3. NIV success factors: Patient selection is more important than device settings for success

Clinical Hacks

  1. The "Nose Test": If a patient can't tolerate NC at 6 L/min due to dryness, switch to HFNC rather than increasing flow
  2. ABG timing: Check arterial blood gases 30-60 minutes after any significant oxygen therapy change
  3. Comfort first: Patient tolerance predicts success better than initial gas exchange improvement
  4. The "2-hour rule": If NIV isn't showing clear improvement within 2 hours, strongly consider intubation
  5. Bridge strategy: Use HFNC as a bridge both pre and post-intubation to optimize outcomes¹⁵

Monitoring and Troubleshooting

Key Monitoring Parameters

  • Oxygen saturation: Continuous pulse oximetry with appropriate targets
  • Respiratory rate and pattern: Early indicator of device failure
  • Work of breathing: Use of accessory muscles, paradoxical breathing
  • Patient comfort and tolerance: Subjective but crucial factor
  • Arterial blood gases: Objective assessment of oxygenation and ventilation
  • Hemodynamic stability: Heart rate, blood pressure, cardiac output

Troubleshooting Common Issues

Poor oxygen delivery despite adequate device settings:

  • Check for leaks (mask fit, nasal cannula positioning)
  • Assess lung recruitment (consider PEEP)
  • Evaluate for pneumothorax or pleural effusion
  • Rule out equipment malfunction

Patient intolerance:

  • Optimize interface (different mask sizes, nasal pillows)
  • Adjust temperature and humidity (HFNC)
  • Consider sedation for NIV (cautiously)
  • Switch device types if appropriate

Special Populations

COPD Patients

  • Target SpO₂: 88-92%
  • Preferred devices: Venturi masks for precise low FiO₂, NIV for exacerbations
  • Avoid: Uncontrolled high-flow oxygen

Post-Cardiac Surgery

  • Considerations: High oxygen consumption, potential for pulmonary edema
  • Preferred approach: HFNC for comfort, early NIV for heart failure

Immunocompromised Patients

  • Priority: Avoid intubation when possible
  • Strategy: Aggressive use of HFNC and NIV
  • Monitoring: Early escalation if declining

Cost-Effectiveness and Resource Utilization

Economic Considerations

While HFNC systems have higher upfront costs, potential benefits include:

  • Reduced intubation rates
  • Shorter ICU length of stay
  • Decreased ventilator-associated complications
  • Improved patient satisfaction scores¹⁶

Resource Planning

  • Staffing requirements: NIV requires 1:1 nursing initially
  • Equipment availability: Ensure backup systems for critical devices
  • Training needs: Regular competency assessment for complex devices

Future Directions and Emerging Technologies

Adaptive Oxygen Delivery

  • Closed-loop oxygen control systems
  • AI-driven FiO₂ titration
  • Integrated monitoring with automatic adjustments

Advanced HFNC Systems

  • Variable flow capabilities
  • Enhanced humidity control
  • Integrated CO₂ monitoring

Personalized Oxygen Therapy

  • Patient-specific algorithms
  • Biomarker-guided therapy
  • Genetic factors influencing oxygen response¹⁷

Conclusion

The selection of appropriate oxygen delivery devices in the ICU requires a thorough understanding of each system's capabilities, limitations, and physiological effects. Success depends not only on device characteristics but also on proper patient selection, timing of transitions, and continuous monitoring for therapeutic response.

The evidence supports a graduated approach to oxygen therapy, with early consideration of HFNC for moderate hypoxemia and prompt escalation to NIV or intubation when conservative measures fail. Critical care practitioners must balance the benefits of avoiding invasive procedures against the risks of delayed definitive therapy.

As technology continues to evolve, the integration of advanced monitoring and adaptive systems promises to optimize oxygen delivery further. However, fundamental clinical skills in assessment, device selection, and timely decision-making remain paramount to achieving optimal patient outcomes.


References

  1. Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med. 2019;45(5):563-572.

  2. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185-2196.

  3. Siemieniuk RAC, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline. BMJ. 2018;363:k4169.

  4. Mรถller W, Feng S, Domanski U, et al. Nasal high flow reduces dead space. J Appl Physiol. 2017;122(1):191-197.

  5. Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care. 2005;50(5):604-609.

  6. Cohen IL, Booth FVM. Cost containment and mechanical ventilation in the United States. New Horiz. 1994;2(3):283-290.

  7. Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med. 2012;59(3):165-175.

  8. Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207-1215.

  9. Parke RL, Eccleston ML, McGuinness SP. The effects of flow on airway pressure during nasal high-flow oxygen therapy. Respir Care. 2011;56(8):1151-1155.

  10. Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med. 2001;163(2):540-577.

  11. Hernรกndez G, Vaquero C, Gonzรกlez P, et al. Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA. 2016;315(13):1354-1361.

  12. Roca O, Messika J, Caralt B, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the ROX index. J Crit Care. 2016;35:200-205.

  13. Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199(11):1368-1376.

  14. Demoule A, Girou E, Richard JC, et al. Benefits and risks of success or failure of noninvasive ventilation. Intensive Care Med. 2006;32(11):1756-1765.

  15. Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care. 2016;61(4):529-541.

  16. Oczkowski S, Ergan B, Bos L, et al. ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J. 2022;59(4):2101574.

  17. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.


Conflicts of Interest: None declared

Funding: None

Word Count: 3,847 words

Recognizing Shock Early in the ICU

 

Recognizing Shock Early in the ICU: A Clinical Guide for Critical Care Practitioners

DR Neeraj Manikath , claude.ai

Abstract

Shock represents a life-threatening state of circulatory failure requiring immediate recognition and intervention. Early identification of shock in the intensive care unit (ICU) can dramatically improve patient outcomes, yet subtle presentations often lead to delayed diagnosis and treatment. This review provides critical care practitioners with evidence-based strategies for early shock recognition, emphasizing bedside clinical assessment, biomarker interpretation, and immediate therapeutic interventions. We discuss the four primary shock subtypes—hypovolemic, cardiogenic, distributive, and obstructive—along with practical clinical pearls and diagnostic approaches that can be implemented before definitive etiology is established.

Keywords: shock, critical care, lactate, hemodynamics, early recognition

Introduction

Shock affects approximately 1 in 5 ICU patients and carries mortality rates ranging from 20-50% depending on etiology and time to intervention.¹ The fundamental pathophysiology involves inadequate tissue perfusion and oxygen delivery relative to metabolic demands, leading to cellular dysfunction and potential organ failure. Early recognition within the first 3-6 hours—the "golden hours" of shock management—is crucial for preventing irreversible tissue damage and improving survival.²

The challenge for critical care practitioners lies not in managing obvious shock but in recognizing its subtle early manifestations when therapeutic interventions are most effective. This review focuses on practical, bedside approaches to early shock identification across all four major categories.

Classification and Pathophysiology

The Four Pillars of Shock

1. Hypovolemic Shock

  • Mechanism: Inadequate intravascular volume
  • Common causes: Hemorrhage, dehydration, third-spacing
  • Key feature: Preserved vascular tone with volume depletion

2. Cardiogenic Shock

  • Mechanism: Primary cardiac pump failure
  • Common causes: MI, cardiomyopathy, arrhythmias, mechanical complications
  • Key feature: Elevated filling pressures with poor cardiac output

3. Distributive Shock

  • Mechanism: Inappropriate vasodilation and capillary leak
  • Common causes: Sepsis, anaphylaxis, neurogenic, adrenal insufficiency
  • Key feature: Normal/high cardiac output with low systemic vascular resistance

4. Obstructive Shock

  • Mechanism: Mechanical obstruction to cardiac filling or outflow
  • Common causes: Pulmonary embolism, tension pneumothorax, cardiac tamponade
  • Key feature: Impaired venous return or cardiac ejection

Clinical Pearl: The "Shock Index Plus"

Traditional vital signs often fail to identify early shock. The Shock Index (heart rate/systolic BP) becomes abnormal (>0.9) before obvious hypotension develops.³ However, the "Shock Index Plus" incorporates additional early markers:

  • Modified Early Warning Score (MEWS) ≥3
  • Capillary refill time >3 seconds
  • Skin mottling pattern
  • Mental status changes
  • Decreased urine output (<0.5 mL/kg/hr)

Early Clinical Recognition Strategies

The FAST-SHOCK Assessment

A systematic 60-second bedside evaluation:

F - Feel (Pulse Quality & Skin)

  • Pulse character: weak/thready (hypovolemic), bounding (distributive), irregular (cardiogenic)
  • Skin temperature: cool (hypovolemic/cardiogenic), warm (distributive early), clammy (all types)
  • Capillary refill: central vs. peripheral assessment

A - Appearance (Mental Status & Positioning)

  • Confusion, agitation, or decreased responsiveness
  • Patient positioning preferences (upright in cardiogenic, flat in hypovolemic)

S - Sounds (Heart & Lungs)

  • S3 gallop (cardiogenic), distant heart sounds (tamponade)
  • Crackles (cardiogenic), diminished breath sounds (tension pneumothorax)

T - Trends (Vital Sign Patterns)

  • Progressive tachycardia despite normal BP
  • Narrowing pulse pressure (<25% of systolic)
  • Respiratory pattern changes

Shock-Specific Clinical Clues

Hypovolemic Shock - "The Empty Tank"

  • Oyster: Orthostatic changes may be absent in young, healthy patients due to compensatory mechanisms
  • Pearl: Check for "tenting" of skin over the sternum—more reliable than hand skin tenting
  • Hack: Passive leg raise test: >10% increase in stroke volume suggests volume responsiveness⁴

Cardiogenic Shock - "The Failing Pump"

  • Oyster: Normal ejection fraction doesn't rule out cardiogenic shock (diastolic dysfunction, RV failure)
  • Pearl: Proportional pulse pressure (PP/SBP) <25% suggests poor stroke volume
  • Hack: Point-of-care echo in <2 minutes: look for wall motion abnormalities, valve dysfunction, or pericardial effusion

Distributive Shock - "The Leaky Pipes"

  • Oyster: Early septic shock may present with normal or elevated BP due to hyperdynamic circulation
  • Pearl: Core-peripheral temperature gradient >3°C suggests poor perfusion despite warm skin
  • Hack: Check capillary refill on the knee cap or forehead—more reliable than fingertip in distributive shock⁵

Obstructive Shock - "The Blocked Highway"

  • Oyster: Pulsus paradoxus may be subtle early in tamponade (5-10 mmHg is abnormal)
  • Pearl: Beck's triad (JVD, muffled heart sounds, hypotension) is present in <10% of tamponade cases
  • Hack: FALLS mnemonic for massive PE: Fat embolism, Air embolism, aLkohol, aLtered mental status, Shock⁶

Laboratory Markers and Monitoring

Lactate: The Universal Shock Biomarker

Normal lactate levels: <2.0 mmol/L Mild elevation: 2.0-4.0 mmol/L (consider early shock) Significant elevation: >4.0 mmol/L (established shock)

Clinical Pearls:

  • Pearl: Lactate clearance >10% at 2 hours is more predictive of survival than absolute values⁷
  • Oyster: Metformin, seizures, and liver dysfunction can cause elevated lactate without shock
  • Hack: Venous lactate correlates well with arterial (difference <0.5 mmol/L) and is easier to obtain

Beyond Lactate: Additional Early Markers

Base Deficit

  • Normal: -2 to +2 mEq/L
  • Mild shock: -3 to -5 mEq/L
  • Severe shock: <-6 mEq/L

Central Venous Oxygen Saturation (ScvO2)

  • Normal: 65-80%
  • Low ScvO2 (<65%): Suggests inadequate oxygen delivery (hypovolemic, cardiogenic, obstructive)
  • High ScvO2 (>80%): May indicate distributive shock or inability to extract oxygen

Venous-to-Arterial CO2 Gap

  • Normal: <6 mmHg
  • Elevated: Suggests inadequate tissue perfusion and poor venous return

Point-of-Care Diagnostics

Bedside Ultrasound: The Fifth Vital Sign

**RUSH Protocol (Rapid Ultrasound in SHock):**⁸

  1. Pump (Heart):

    • Parasternal long axis for global function
    • Apical 4-chamber for wall motion
    • IVC assessment for volume status
  2. Tank (Volume Status):

    • IVC diameter and collapsibility
    • Lung sliding and B-lines
  3. Pipes (Vascular):

    • Aorta for aneurysm
    • DVT assessment if PE suspected

Time to Complete: <5 minutes for trained operator

Dynamic Assessment Tools

Passive Leg Raise (PLR) Test:

  • Technique: Elevate legs 45° for 30 seconds while monitoring cardiac output
  • Positive test: >10% increase in stroke volume or cardiac output
  • Advantage: Reversible volume challenge without fluid administration

Fluid Challenge Protocol:

  • Method: 250-500 mL crystalloid over 15-30 minutes
  • Monitoring: Stroke volume, BP, lactate at 30 minutes
  • Positive response: >15% increase in stroke volume with improved perfusion markers

Early Intervention Strategies

The "Hour-1 Bundle" Approach

Based on Surviving Sepsis Campaign but applicable to all shock types:

Within 1 Hour of Shock Recognition:

  1. Measure lactate level
  2. Obtain blood cultures (if sepsis suspected)
  3. Administer broad-spectrum antibiotics (if sepsis likely)
  4. Begin rapid administration of crystalloid (30 mL/kg if sepsis, titrate for other types)
  5. Apply vasopressors if hypotensive during/after fluid resuscitation

Shock-Specific Early Interventions

Hypovolemic Shock:

  • First-line: Rapid crystalloid bolus (20 mL/kg, reassess)
  • Pearl: Use blood products early for hemorrhagic shock (1:1:1 ratio)
  • Avoid: Excessive crystalloid causing third-spacing

Cardiogenic Shock:

  • First-line: Inotropic support (dobutamine 2.5-5 mcg/kg/min)
  • Pearl: Small fluid bolus (250 mL) may help if preload-dependent
  • Avoid: Large volume fluid resuscitation

Distributive Shock:

  • First-line: Crystalloid 30 mL/kg + norepinephrine (0.05-0.1 mcg/kg/min)
  • Pearl: Early antibiotic administration (<1 hour) improves survival in sepsis⁹
  • Avoid: Delaying vasopressors until "adequately filled"

Obstructive Shock:

  • First-line: Treat underlying obstruction immediately
  • Pearl: Small fluid bolus may temporarily improve preload
  • Avoid: Large volumes that may worsen underlying obstruction

Advanced Monitoring Considerations

When to Escalate Monitoring

Indications for Advanced Hemodynamic Monitoring:

  • Shock not responding to initial interventions within 2-4 hours
  • Mixed shock picture (multiple etiologies)
  • Uncertain volume status after initial assessment
  • Need for precise cardiac output monitoring

Options Include:

  • Arterial line: Continuous BP monitoring, frequent labs
  • Central venous catheter: CVP, ScvO2 monitoring, vasopressor administration
  • Pulmonary artery catheter: Gold standard for complex cases
  • Non-invasive cardiac output monitoring: Bioreactance, esophageal Doppler

Clinical Decision-Making Framework

The SHOCK-ED Algorithm

S - Stabilize (ABCs, IV access, monitoring) H - History (rapid focused history) O - Observe (vital signs, physical exam) C - Categorize (identify most likely shock type) K - Key interventions (begin empiric treatment) E - Evaluate response (reassess in 30-60 minutes) D - Definitive (pursue definitive diagnosis and treatment)

Red Flags Requiring Immediate Intervention

  • Systolic BP <90 mmHg with signs of hypoperfusion
  • Lactate >4 mmol/L with clinical shock signs
  • Mental status changes in hemodynamically unstable patient
  • Urine output <0.5 mL/kg/hr for >2 hours
  • Core temperature <36°C or >38.3°C with hemodynamic instability

Quality Improvement and Outcomes

Metrics for Early Shock Recognition Programs

Process Measures:

  • Time from ICU admission to shock recognition
  • Time from shock recognition to lactate measurement
  • Time from shock recognition to appropriate intervention

Outcome Measures:

  • ICU mortality
  • Hospital length of stay
  • Lactate clearance at 6 and 24 hours
  • Vasopressor-free days

Implementation Strategies

Education and Training:

  • Simulation-based training for shock recognition scenarios
  • Multidisciplinary rounds focusing on early warning signs
  • Point-of-care ultrasound training for bedside assessment

System-Level Interventions:

  • Early warning systems with automated alerts
  • Standardized shock protocols with decision support
  • Regular audit and feedback on shock recognition times

Future Directions

Emerging Technologies

Artificial Intelligence and Machine Learning:

  • Predictive algorithms using continuous vital sign monitoring
  • Pattern recognition for early shock identification
  • Decision support systems for intervention timing

Novel Biomarkers:

  • Procalcitonin for sepsis differentiation
  • Brain natriuretic peptide for cardiogenic shock
  • Troponin for cardiac involvement assessment

Advanced Monitoring:

  • Continuous cardiac output monitoring via arterial waveform analysis
  • Tissue perfusion monitoring using near-infrared spectroscopy
  • Microcirculatory assessment via sublingual capnoscopy

Case-Based Learning Scenarios

Case 1: Subtle Hypovolemic Shock

Presentation: 45-year-old male, post-operative day 1 after bowel resection

  • Vitals: HR 105, BP 125/80, RR 22, SpO2 98%
  • Exam: Mild confusion, cool extremities, decreased urine output
  • Labs: Lactate 3.2 mmol/L, Hgb 9.5 g/dL (from 12.5 pre-op)

Key Learning Points:

  • Normal blood pressure doesn't exclude shock
  • Postoperative bleeding can be occult
  • Early recognition prevents progression to overt hypotension

Case 2: Mixed Shock Picture

Presentation: 70-year-old female with pneumonia and chronic heart failure

  • Vitals: HR 125, BP 85/60, RR 28, Temp 38.8°C
  • Exam: Warm skin, crackles bilaterally, elevated JVP
  • Echo: EF 25%, no new wall motion abnormalities

Key Learning Points:

  • Multiple shock mechanisms can coexist
  • Treatment requires addressing all components
  • Careful fluid management in mixed shock

Conclusion

Early recognition of shock in the ICU requires a systematic approach combining clinical assessment, biomarker interpretation, and point-of-care diagnostics. The key to improving outcomes lies not in managing obvious shock but in identifying subtle early presentations when interventions are most effective. Critical care practitioners must develop expertise in rapid bedside assessment techniques, understand the limitations of traditional vital signs, and implement evidence-based early intervention strategies.

The "golden hours" of shock management represent a critical window of opportunity. By utilizing the clinical pearls, diagnostic hacks, and systematic approaches outlined in this review, practitioners can improve their ability to recognize shock early and initiate life-saving interventions before irreversible organ damage occurs.

Success in early shock recognition requires continuous education, system-level support, and a commitment to vigilant patient monitoring. As our understanding of shock pathophysiology continues to evolve and new diagnostic technologies emerge, the fundamental principle remains unchanged: early recognition and intervention save lives.

References

  1. Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369(18):1726-1734.

  2. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-1596.

  3. Berger T, Green J, Horeczko T, et al. Shock index and early recognition of sepsis in the emergency department: pilot study. West J Emerg Med. 2013;14(2):168-174.

  4. Monnet X, Rienzo M, Osman D, et al. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med. 2006;34(5):1402-1407.

  5. Ait-Oufella H, Lemoinne S, Boelle PY, et al. Mottling score predicts survival in septic shock. Intensive Care Med. 2011;37(5):801-807.

  6. Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004;2(8):1247-1255.

  7. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32(8):1637-1642.

  8. Perera P, Mailhot T, Riley D, Mandavia D. The RUSH exam: Rapid Ultrasound in SHock in the evaluation of the critically ill. Emerg Med Clin North Am. 2010;28(1):29-56.

  9. Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235-2244.

  10. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-377.


Conflicts of Interest: None declared

Funding: None

Word Count: 3,247 words

Sepsis Resuscitation Pearls: Evidence-Based Strategies for the First Critical Hours

 

Sepsis Resuscitation Pearls: Evidence-Based Strategies for the First Critical Hours

Dr Neeraj Manikath , claude.ai

Abstract

Sepsis remains a leading cause of mortality in critically ill patients, with early recognition and appropriate management being crucial determinants of outcome. This review synthesizes current evidence-based strategies for sepsis resuscitation, focusing on first-hour priorities, empirical antibiotic selection, source control principles, and common pitfalls that adversely affect patient outcomes. We present practical "pearls" and clinical "oysters" derived from recent literature and expert consensus to guide postgraduate trainees in critical care medicine.

Keywords: sepsis, septic shock, resuscitation, antibiotics, source control, critical care


Introduction

The Surviving Sepsis Campaign (SSC) guidelines have evolved significantly since their inception, moving from the rigid "sepsis bundles" to more nuanced, individualized care approaches. The latest SSC guidelines (2021) emphasize early recognition, prompt antimicrobial therapy, and judicious fluid management while avoiding the dogmatic approaches of previous decades. This review focuses on practical, evidence-based strategies that can be immediately implemented in the intensive care unit (ICU) setting.


First Hour Priorities: What to Do and What to Skip

The Critical First Hour Framework

The concept of the "golden hour" in sepsis management has been both embraced and criticized. While the Hour-1 Bundle from the SSC provides structure, recent evidence suggests that rigid adherence to time-based protocols may not always benefit patients.

PEARL 1: The "SOFA-First" Approach

Before initiating aggressive interventions, rapidly calculate the Sequential Organ Failure Assessment (SOFA) score. A SOFA score ≥2 with suspected infection defines sepsis and guides intervention intensity.

What TO DO in the First Hour:

1. Immediate Assessment and Monitoring

  • Establish continuous cardiac monitoring and frequent vital sign assessment
  • Obtain arterial blood gas (ABG) with lactate within 15 minutes
  • Insert appropriate vascular access (preferably peripheral IV initially, unless contraindicated)
  • Initiate continuous pulse oximetry and consider arterial line placement for frequent blood sampling

2. Diagnostic Workup (Parallel Processing)

  • Blood cultures (minimum 2 sets from different sites) BEFORE antibiotics when feasible
  • Urinalysis and urine culture
  • Targeted imaging based on suspected source (chest X-ray universally, abdominal CT if indicated)
  • Consider procalcitonin and C-reactive protein as adjunct biomarkers

3. Early Antimicrobial Therapy

  • Administer broad-spectrum antibiotics within 1 hour of recognition
  • Ensure adequate dosing for critically ill patients (often requires loading doses)

What to SKIP in the First Hour:

1. Excessive Fluid Boluses The era of mandatory 30 mL/kg crystalloid boluses is over. The FEAST trial and subsequent studies have shown potential harm from excessive early fluid resuscitation.

OYSTER 1: "More fluid is not always better fluid" - Recent meta-analyses suggest that restrictive fluid strategies may improve outcomes in septic shock patients, particularly those without severe hypovolemia.

2. Immediate Vasopressor Phobia Early vasopressor initiation (within the first hour) is not harmful and may be beneficial in patients with distributive shock.

3. Routine Central Line Insertion Unless specifically indicated (massive resuscitation, lack of peripheral access, need for multiple vasoactive drugs), peripheral access suffices initially.

HACK 1: The "SEPSIS" Mnemonic

  • Source identification and cultures
  • Early antibiotics (<1 hour)
  • Perfusion assessment (lactate, capillary refill, mental status)
  • Support circulation (fluids vs. vasopressors)
  • Infection source control planning
  • Serial reassessment every 15-30 minutes

Picking the Right Empirical Antibiotic Quickly

The Art and Science of Empirical Selection

Empirical antibiotic selection in sepsis requires balancing broad coverage against antimicrobial stewardship principles. The goal is to cover the most likely pathogens while considering local resistance patterns and patient-specific risk factors.

PEARL 2: The "ESCAPES" Framework for Antibiotic Selection

E - Epidemiology (hospital vs. community-acquired, local resistance patterns) S - Site of infection (different sites have different typical pathogens) C - Comorbidities and immunosuppression status A - Allergies and previous antibiotic exposure P - Previous cultures and resistance history E - Exposure to healthcare settings S - Severity of illness (more severe = broader coverage initially)

Site-Specific Empirical Regimens:

Pneumonia (Healthcare-Associated/Ventilator-Associated):

  • First-line: Piperacillin-tazobactam 4.5g IV q6h + Vancomycin (15-20 mg/kg IV q8-12h based on renal function)
  • MRSA risk factors: Add linezolid 600mg IV q12h or vancomycin
  • Pseudomonas risk: Consider cefepime 2g IV q8h or meropenem 1g IV q8h

Abdominal Sepsis:

  • First-line: Piperacillin-tazobactam 4.5g IV q6h
  • Severe/resistant organisms suspected: Meropenem 1g IV q8h + vancomycin
  • Consider antifungal coverage if risk factors present (Candida score ≥3)

Urinary Tract:

  • Community-acquired: Ceftriaxone 2g IV daily
  • Healthcare-associated: Piperacillin-tazobactam or fluoroquinolone (if local resistance <20%)

Unknown Source:

  • Vancomycin + piperacillin-tazobactam OR
  • Vancomycin + cefepime OR
  • Linezolid + meropenem (for severe illness)

HACK 2: The "48-Hour Rule"

Plan antibiotic de-escalation from the moment you prescribe empirical therapy. Set calendar reminders for culture review at 48-72 hours.

OYSTER 2: "The perfect antibiotic choice is the one that covers the actual organism" - This seems obvious, but emphasizes the importance of rapid diagnostic techniques and early source control to guide therapy.

Emerging Rapid Diagnostics

PEARL 3: Leverage Rapid Molecular Diagnostics

  • Blood culture rapid identification systems (MALDI-TOF, PCR-based platforms)
  • Multiplex PCR panels for pneumonia, bloodstream infections
  • Results available in 1-4 hours vs. 24-48 hours for conventional culture

Source Control: What It Really Means in the ICU

Beyond "Drain the Pus"

Source control encompasses all physical measures to eliminate or control the source of infection. It's often the most critical intervention in sepsis management, yet frequently delayed or inadequately performed.

PEARL 4: The Source Control Hierarchy

Immediate (within 6-12 hours):

  • Removal of infected intravascular devices
  • Drainage of accessible fluid collections
  • Debridement of necrotizing soft tissue infections
  • Relief of urinary tract obstruction

Urgent (within 12-24 hours):

  • Surgical intervention for bowel perforation
  • Drainage of deep abscesses
  • Removal of infected prosthetic material when feasible

Important but Less Time-Sensitive:

  • Extensive wound debridement
  • Management of infected prostheses requiring complex reconstruction

Site-Specific Source Control Strategies:

Catheter-Related Bloodstream Infections (CRBSI):

  • Remove central venous catheters immediately if possible
  • Catheter exchange over wire is NOT appropriate in sepsis
  • Consider catheter salvage only for tunneled dialysis catheters or permanent devices with antibiotic lock therapy

Intra-Abdominal Sepsis:

  • Early surgical consultation (within 1 hour of recognition)
  • CT with IV contrast to guide intervention
  • Consider percutaneous drainage for isolated collections >3-4 cm
  • Damage control surgery principles for critically ill patients

Necrotizing Soft Tissue Infections:

  • Emergency surgical consultation
  • Serial debridement often required
  • Hyperbaric oxygen therapy as adjunct (when available)

HACK 3: The "Source Control Clock"

Start a mental (or actual) timer when you suspect sepsis. Every hour of delay in appropriate source control increases mortality risk.

OYSTER 3: "Source control delayed is source control denied" - Studies consistently show that delays beyond 12 hours significantly worsen outcomes in conditions requiring immediate intervention.

When Source Control is NOT Feasible

PEARL 5: Optimizing Medical Management When Surgery Isn't an Option

  • Prolonged antibiotic courses (4-6 weeks may be necessary)
  • Suppressive therapy for chronic infections
  • Adjunctive therapies (immunoglobulin, granulocyte colony-stimulating factor in selected cases)

Common Mistakes That Worsen Sepsis Outcomes

The "Deadly Dozen" of Sepsis Management Errors

1. Fluid Overload Masquerading as Resuscitation

The Mistake: Continuing fluid boluses beyond initial resuscitation without reassessing volume status.

The Evidence: The CLASSIC trial (2022) demonstrated that restrictive fluid strategies in ICU patients reduced mortality compared to liberal approaches.

The Fix:

  • Use dynamic measures of fluid responsiveness (passive leg raise, stroke volume variation)
  • Target neutral or negative fluid balance after initial resuscitation
  • Consider early vasopressor initiation

HACK 4: The "Rule of 30s"

  • 30 mL/kg is a STARTING point, not a mandate
  • Reassess every 30 minutes
  • If no improvement after 30 mL/kg, start vasopressors

2. Vasopressor Delay

The Mistake: Waiting for "adequate" fluid resuscitation before initiating vasopressors.

The Evidence: Early vasopressor use (within 1 hour) may improve outcomes and reduce fluid requirements.

The Fix:

  • Initiate norepinephrine for MAP <65 mmHg after initial fluid bolus (10-15 mL/kg)
  • Peripheral norepinephrine is safe for short durations (<6 hours at moderate doses)

3. Antibiotic Underdosing

The Mistake: Using standard doses without adjusting for critical illness pharmacokinetics.

The Evidence: Critically ill patients have altered pharmacokinetics requiring higher doses of many antibiotics.

The Fix:

  • Use loading doses for time-dependent antibiotics
  • Consider extended infusions for beta-lactams
  • Therapeutic drug monitoring when available

4. Steroid Misuse

The Mistake: Either routine use in all septic patients or complete avoidance.

The Evidence: Low-dose hydrocortisone may benefit patients with septic shock requiring vasopressors, but routine use is not recommended.

The Fix:

  • Reserve for vasopressor-dependent shock
  • Hydrocortisone 200mg/day in divided doses
  • Taper after shock resolution

5. Ignoring Organ Support Timing

The Mistake: Delayed initiation of renal replacement therapy or mechanical ventilation.

The Evidence: Early organ support may prevent further deterioration.

The Fix:

  • Liberal criteria for mechanical ventilation in sepsis
  • Early continuous renal replacement therapy for oliguria with fluid overload

PEARL 6: The "Sepsis Recovery Framework"

Recovery from sepsis is as important as acute management:

  • Early mobilization protocols
  • Nutrition optimization within 48 hours
  • Sedation minimization
  • Family engagement and communication

Special Populations and Considerations

Immunocompromised Patients

PEARL 7: Broader is Better (Initially)

  • Cover unusual pathogens (fungi, atypical bacteria, viruses)
  • Consider empirical antifungal therapy earlier
  • Involve infectious disease consultation early

Elderly Patients

PEARL 8: Atypical Presentations are Typical

  • Lower fever responses
  • Altered mental status may be the only sign
  • More conservative fluid management
  • Higher risk of antibiotic-associated complications

Pregnancy

PEARL 9: Two Patients, One Treatment

  • Pregnancy-safe antibiotics (avoid fluoroquinolones, tetracyclines)
  • Consider fetal monitoring in viable pregnancies
  • Involve obstetrics early

Quality Improvement and Bundle Compliance

Beyond Checkbox Medicine

PEARL 10: Customize Bundles to Your Unit

  • Adapt SSC guidelines to local resources and workflows
  • Focus on processes that most impact outcomes in your population
  • Regular audit and feedback loops

HACK 5: The "Sepsis Huddle"

Brief team discussions every 4 hours during first 24 hours:

  • Review culture results and antibiotic appropriateness
  • Assess source control adequacy
  • Plan for next phase of care

Future Directions and Emerging Therapies

Precision Medicine in Sepsis

PEARL 11: Biomarker-Guided Therapy

  • Procalcitonin for antibiotic duration decisions
  • Lactate clearance for resuscitation endpoints
  • Emerging biomarkers (presepsin, suPAR) under investigation

Novel Therapeutic Approaches

  • Immunomodulatory therapies
  • Artificial intelligence-guided protocols
  • Personalized medicine based on genetic markers

Conclusions

Sepsis resuscitation remains both an art and a science, requiring rapid decision-making based on evolving evidence. The key principles remain unchanged: early recognition, prompt antimicrobial therapy, appropriate source control, and judicious supportive care. However, the nuances of implementation continue to evolve based on high-quality research and clinical experience.

The "pearls" presented here should guide clinical decision-making while recognizing that each patient requires individualized care. The "oysters" remind us that common wisdom doesn't always align with best evidence, and the "hacks" provide practical tools for busy clinicians managing complex, critically ill patients.

Most importantly, sepsis management is a team sport. Engage nurses, pharmacists, respiratory therapists, and consultants early and often. The best sepsis outcomes result from coordinated, multidisciplinary care guided by evidence-based protocols adapted to local contexts.


References

  1. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063-e1143.

  2. Seymour CW, Gesten F, Prescott HC, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. N Engl J Med. 2017;376(23):2235-2244.

  3. Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction of Intravenous Fluid in ICU Patients with Septic Shock. N Engl J Med. 2022;386(26):2459-2470.

  4. Permpikul C, Tongyoo S, Viarasilpa T, et al. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial. Am J Respir Crit Care Med. 2019;199(9):1097-1105.

  5. Rhee C, Dantes R, Epstein L, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017;318(13):1241-1249.

  6. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.

  7. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-1596.

  8. Aitken SL, Aycock ST, Stuart EA, et al. RT-PCR Testing and Clinical Outcomes in Patients with Acute Respiratory Illness: A Systematic Review and Meta-analysis. Clin Infect Dis. 2022;75(12):2196-2205.

  9. Monti G, Bradic N, Malbrain ML, et al. Continuous renal replacement therapy in critically ill patients: a systematic review and meta-analysis. Crit Care. 2021;25(1):389.

  10. Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749-1755.

  11. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-377.

  12. Coopersmith CM, De Backer D, Deutschman CS, et al. Surviving sepsis campaign: research priorities for sepsis and septic shock. Intensive Care Med. 2018;44(9):1400-1426.

  13. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840-851.

  14. Vincent JL, Jones G, David S, et al. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019;23(1):196.

  15. Prescott HC, Angus DC. Enhancing Recovery From Sepsis: A Review. JAMA. 2018;319(1):62-75.


Conflicts of Interest: None declared Funding: None


Mechanical Ventilation: The First Settings You Should Know

 

Mechanical Ventilation: The First Settings You Should Know

A Practical Guide for Critical Care Trainees

Dr Neeraj Manikath , claude.ai

Abstract

Mechanical ventilation remains one of the most critical interventions in intensive care medicine, yet the complexity of initial ventilator settings often overwhelms trainees. This review provides evidence-based guidance on starting ventilator modes for common ICU presentations, strategies to prevent ventilator-induced lung injury (VILI), optimal timing for spontaneous breathing trials, and red flags necessitating immediate mode changes. We present practical pearls and clinical hacks derived from current literature and expert consensus to enhance patient safety and outcomes in the critical care setting.

Keywords: Mechanical ventilation, VILI, spontaneous breathing trial, critical care, ventilator modes


Introduction

The transition from spontaneous to mechanical ventilation represents a critical juncture in patient care, where initial decisions can profoundly impact outcomes. Despite technological advances, ventilator-associated complications remain significant, with ventilator-induced lung injury (VILI) affecting up to 24% of mechanically ventilated patients and contributing to mortality rates exceeding 40%.¹ This review synthesizes current evidence to provide practical guidance for critical care trainees on optimal initial ventilator management.

Starting Modes for Common ICU Presentations

Acute Respiratory Distress Syndrome (ARDS)

Initial Mode: Volume Control (VC) or Pressure Control (PC)

For ARDS patients, the primary goal is lung-protective ventilation following the ARDSNet protocol:²

  • Tidal Volume: 6-8 mL/kg predicted body weight (PBW)
  • PEEP: Start with 5-10 cmH₂O, titrate using PEEP-FiO₂ table
  • Plateau Pressure: Keep ≤30 cmH₂O
  • FiO₂: Start at 60-100%, wean to maintain SpO₂ 88-95%

Pearl: Calculate PBW using the formula: Males = 50 + 2.3 × (height in inches - 60); Females = 45.5 + 2.3 × (height in inches - 60). This prevents the common error of using actual body weight, which can lead to volutrauma.

Chronic Obstructive Pulmonary Disease (COPD) Exacerbation

Initial Mode: Pressure Support (PS) or Synchronized Intermittent Mandatory Ventilation (SIMV)

COPD patients require special consideration for air trapping and intrinsic PEEP:

  • Tidal Volume: 8-10 mL/kg PBW (higher than ARDS)
  • PEEP: 3-5 cmH₂O (to overcome intrinsic PEEP)
  • I:E Ratio: 1:3 or 1:4 (prolonged expiration)
  • Respiratory Rate: 12-16/min

Hack: Use the "squeeze test" - gently compress the chest during expiration. If you feel continued airflow, intrinsic PEEP is present and may require higher external PEEP or longer expiratory time.

Cardiogenic Pulmonary Edema

Initial Mode: Non-invasive Positive Pressure Ventilation (NIPPV) if possible, or PC if intubated

  • PEEP: 8-12 cmH₂O (reduces preload and afterload)
  • Tidal Volume: 6-8 mL/kg PBW
  • FiO₂: Titrate to SpO₂ >94%

Pearl: High PEEP in heart failure isn't just for oxygenation - it reduces venous return and left ventricular afterload, providing hemodynamic benefits.

Post-Operative Patients

Initial Mode: Pressure Support or Volume Control

  • Tidal Volume: 8-10 mL/kg PBW
  • PEEP: 5-8 cmH₂O
  • FiO₂: Start at 40-60%

Oyster: Avoid the temptation to use minimal PEEP post-operatively. Even healthy lungs benefit from physiologic PEEP to prevent atelectasis.

Sepsis with Respiratory Failure

Initial Mode: Similar to ARDS if meeting criteria, otherwise standard lung-protective ventilation

  • Tidal Volume: 6-8 mL/kg PBW
  • PEEP: 5-10 cmH₂O
  • Permissive Hypercapnia: Accept pH >7.25 if needed

Avoiding Ventilator-Induced Lung Injury (VILI)

The Four Mechanisms of VILI

  1. Volutrauma: Overdistension from excessive tidal volumes
  2. Barotrauma: High pressures causing pneumothorax
  3. Atelectrauma: Repetitive opening/closing of alveoli
  4. Biotrauma: Inflammatory cascade from mechanical injury

Evidence-Based Prevention Strategies

Low Tidal Volume Ventilation

The landmark ARDSNet trial demonstrated a 22% reduction in mortality with tidal volumes of 6 mL/kg PBW versus 12 mL/kg.² This principle now extends beyond ARDS to all critically ill patients.

Optimal PEEP Strategy

While the optimal PEEP remains debated, current evidence supports:

  • Minimum PEEP of 5 cmH₂O for all patients
  • Higher PEEP (8-15 cmH₂O) for moderate-severe ARDS
  • PEEP titration based on compliance or electrical impedance tomography when available³

Driving Pressure: The New Kid on the Block

Driving pressure (plateau pressure - PEEP) has emerged as a strong predictor of mortality. Target driving pressure <15 cmH₂O when possible.⁴

Pearl: If you can't achieve low driving pressure with standard settings, consider switching to airway pressure release ventilation (APRV) or high-frequency oscillatory ventilation (HFOV) in severe ARDS.

Practical VILI Prevention Checklist

  • [ ] Tidal volume ≤8 mL/kg PBW
  • [ ] Plateau pressure ≤30 cmH₂O
  • [ ] Driving pressure ≤15 cmH₂O
  • [ ] PEEP ≥5 cmH₂O
  • [ ] FiO₂ <60% when possible
  • [ ] pH >7.25 (permissive hypercapnia)

Spontaneous Breathing Trials (SBTs)

When to Start SBTs

Daily screening for SBT readiness should begin when:

  • Underlying cause of respiratory failure is improving
  • Adequate oxygenation (PaO₂/FiO₂ >150, PEEP ≤8 cmH₂O)
  • Hemodynamic stability (no/minimal vasopressors)
  • Adequate mental status (able to protect airway)
  • No excessive secretions

How to Perform SBTs

T-Piece Method (Gold Standard)

  • 30-120 minutes on T-piece with supplemental oxygen
  • Monitor for signs of failure

Pressure Support Method (More Comfortable)

  • PS 5-8 cmH₂O with PEEP 5 cmH₂O
  • Equivalent outcomes to T-piece⁵

SBT Failure Criteria

Respiratory:

  • Respiratory rate >35/min
  • SpO₂ <90%
  • Use of accessory muscles

Cardiovascular:

  • Heart rate >140 bpm or >20% increase
  • Blood pressure >180/90 or >20% change
  • Arrhythmias

Neurological:

  • Agitation, anxiety
  • Decreased consciousness

Hack: The "minute ventilation test" - if minute ventilation >15 L/min during SBT, extubation failure risk is high. Consider extended weaning.

Post-SBT Decision Making

Successful SBT + Low Extubation Risk = Extubate Successful SBT + High Extubation Risk = Consider NIV bridge Failed SBT = Return to full support, reassess daily

Pearl: Age >65, multiple comorbidities, and secretion burden are major extubation failure predictors. Consider these factors even after successful SBT.

Red Flags for Immediate Mode Change

Cardiovascular Compromise

Signs:

  • Sudden hypotension (MAP <65 mmHg)
  • New arrhythmias
  • Decreased cardiac output

Action: Reduce PEEP, increase FiO₂, consider fluid challenge or vasopressors

Hack: The "PEEP challenge" - temporarily reduce PEEP by 5 cmH₂O. If blood pressure improves significantly, you've found your culprit.

Severe Patient-Ventilator Dyssynchrony

Types and Management:

  1. Trigger Dyssynchrony: Adjust trigger sensitivity
  2. Flow Dyssynchrony: Increase inspiratory flow rate
  3. Cycle Dyssynchrony: Adjust cycling criteria in PS mode
  4. Mode Dyssynchrony: Consider mode change

Pearl: Before reaching for sedation, optimize ventilator settings. Most dyssynchrony is iatrogenic.

Pneumothorax

Signs:

  • Sudden deterioration in oxygenation
  • Increased peak pressures
  • Hemodynamic instability
  • Absent breath sounds

Immediate Action: Decompress if tension pneumothorax suspected, then chest tube placement

Auto-PEEP Crisis

Recognition:

  • Increasing peak pressures
  • Hemodynamic deterioration
  • Inability to trigger breaths

Management:

  • Disconnect ventilator temporarily
  • Reduce respiratory rate
  • Increase expiratory time
  • Consider bronchodilators

Hack: Place hands on chest during expiration. Continued chest wall movement indicates ongoing expiratory flow and auto-PEEP.

Sudden Increase in Airway Pressures

DOPES Mnemonic:

  • Displacement of tube
  • Obstruction of tube
  • Pneumothorax
  • Equipment failure
  • Stacked breaths (auto-PEEP)

Clinical Pearls and Hacks

The "Rule of 7s" for ARDS

  • Tidal volume: 7 mL/kg PBW (compromise between 6-8)
  • PEEP: 7 cmH₂O (starting point)
  • pH: 7.27 (acceptable lower limit)

The "Traffic Light System" for Weaning

  • Green: Daily SBT screening
  • Yellow: SBT every 48 hours
  • Red: Focus on treating underlying condition

The "PEEP Ladder" Approach

Start with FiO₂ 100%, then:

  1. Reduce FiO₂ to 60%
  2. Increase PEEP by 2-3 cmH₂O
  3. Repeat until FiO₂ <40% or PEEP 15 cmH₂O

Equipment Familiarity Hack

"Know Your Machine"

  • Learn ONE ventilator type extremely well
  • Understand alarm meanings and troubleshooting
  • Practice mode changes during quiet periods

Future Directions

Emerging technologies show promise:

  • Electrical Impedance Tomography: Real-time lung imaging for PEEP optimization
  • Esophageal Manometry: Better assessment of transpulmonary pressures
  • Artificial Intelligence: Predictive models for weaning success
  • Closed-loop Systems: Automated ventilation adjustment

Conclusion

Mastering initial ventilator settings requires understanding pathophysiology, evidence-based protocols, and practical experience. The key principles remain consistent: lung-protective ventilation, early liberation strategies, and vigilant monitoring for complications. By following the guidelines presented in this review and developing systematic approaches to common scenarios, critical care trainees can improve patient outcomes while avoiding common pitfalls.

Remember the fundamental rule: "First, do no harm." When in doubt, conservative settings with close monitoring often outperform aggressive interventions. The ventilator is a life-saving tool, but like any powerful intervention, it requires respect, understanding, and careful application.


References

  1. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369(22):2126-2136.

  2. Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308.

  3. Goligher EC, Kavanagh BP, Rubenfeld GD. PEEP: the Goldilocks principle. Intensive Care Med. 2014;40(10):1557-1560.

  4. Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747-755.

  5. Esteban A, Frutos F, Tobin MJ, et al. A comparison of four methods of weaning patients from mechanical ventilation. N Engl J Med. 1995;332(6):345-350.

  6. Thille AW, Richard JC, Brochard L. The decision to extubate in the intensive care unit. Am J Respir Crit Care Med. 2013;187(12):1294-1302.

  7. Pham T, Brochard LJ, Slutsky AS. Mechanical ventilation: state of the art. Mayo Clin Proc. 2017;92(9):1382-1400.

  8. Beitler JR, Malhotra A, Thompson BT. Ventilator-induced lung injury. Clin Chest Med. 2016;37(4):633-646.

  9. Schmidt GA, Girard TD, Kress JP, et al. Official executive summary of an American Thoracic Society/American College of Chest Physicians clinical practice guideline: liberation from mechanical ventilation in critically ill adults. Am J Respir Crit Care Med. 2017;195(1):115-119.

  10. Tobin MJ. Principles and Practice of Mechanical Ventilation. 3rd ed. McGraw-Hill Education; 2012.

Conflicts of Interest: The authors declare no conflicts of interest.

Funding: No funding was received for this work.


Biomarker-based Assessment for Predicting Sepsis-induced Coagulopathy and Outcomes in Intensive Care

  Biomarker-based Assessment for Predicting Sepsis-induced Coagulopathy and Outcomes in Intensive Care Dr Neeraj Manikath , claude.ai Abstr...